These are two worthy contenders for your investment portfolio.
News & Analysis: Novo Nordisk
NVO earnings call for the period ending March 31, 2020.
The health insurer hopes that making prescriptions affordable will keep the people it covers healthier, which should save it money in the long run.
These healthcare stocks can give investors a good mix of dividends and growth.
Led by its diabetes lineup, Novo Nordisk could continue to deliver solid returns in 2020.
Last week, Weight Watchers International rolled out myWW, offering members a customized approach to weight management. But will its new program and its rebranding effort help it recover from slimmer third-quarter revenue results?
The small-cap biopharma inked a deal with a major pharmaceutical company, its second in three weeks.
NVO earnings call for the period ending September 30, 2019.
Which stock wins in a battle between these two healthcare giants?
GLP-1 drugs keep getting easier to take.